General discussions, page-13

The chart is in both a long term and (currently) short term downtrend. Given the Director only sold recently (and a very small portion) Im not sure it fully explains why we are not currently nudging up against the high with the announcement just around the corner.
I belive the real problem is competition. Just because they have a great test does not mean they will be able to sell it. There are many forces at work here that will doing everything to stop them including makers of the current FBT and competitors such as the Galleri blood test.
Management have been very quiet of late apart from re-hashing the same stuff and the market is becomming concerned. Just my opinion.